Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors

Val J. Watts, Kim Neve

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Prolonged stimulation of G(i)-coupled receptors often sensitizes adenylate cyclase to subsequent activation by forskolin or G(s)coupled receptors. To identify mechanisms of heterologous sensitization, we characterized sensitization of cAMP accumulation that was induced by activation of recombinant dopamine D2 receptors expressed in C6 glioma and human embryonic kidney (HEK)293 cells. Pretreatment with dopamine or other agonists for 2 hr induced heterologous sensitization that was blocked by the D2 antagonist spiperone but not by the β-adrenergic receptor antagonist propranolol. Sensitization was evident after 15 min of treatment with dopamine and persisted for at least 2 hr after washout. The EC50 value for sensitization by dopamine in HEK-D(2L) cells was 100 nM, ~80-fold higher than the IC50 value for dopamine inhibition of cAMP accumulation. The D2 receptor agonists quinpirole, 7-hydroxy-dipropylaminotetralin, and pergolide also induced sensitization, whereas the high affinity ergot agonists bromocriptine and lisuride did not. Stimulation of either D(2L) or D(2S) receptors sensitized cAMP accumulation to similar extents, but stimulation of D3 receptors did not. In C6-D(2L) cells, sensitization of isoproterenol- stimulated activity was manifested as a >100% increase in maximal response, with no change in potency. In contrast, the potency for forskolin-stimulated activity was increased 4-fold, with no apparent change in maximal response. Overnight treatment with pertussis toxin (25 ng/ml) had little effect on isoproterenol or forskolin activation of adenylate cyclase per se but prevented D2 receptor-mediated sensitization in both C6-D(2L) and HEK- D(2L) cells, indicating an involvement of one or more of the pertussis toxin- sensitive G proteins, G(i)/G(o). D2 receptor stimulation also sensitized type I and type II adenylate cyclases, each expressed in HEK293 cells together with D(2L) dopamine receptors. Rapid D2 receptor-mediated heterologous sensitization may be the result of enhanced interaction of G(s) with adenylate cyclase and may represent a novel mechanism for modulation of neural activity by D2 receptors.

Original languageEnglish (US)
Pages (from-to)966-976
Number of pages11
JournalMolecular Pharmacology
Volume50
Issue number4
StatePublished - Oct 1996

Fingerprint

Dopamine D2 Receptors
Adenylyl Cyclases
Dopamine
Colforsin
Pertussis Toxin
Kidney
Isoproterenol
Lisuride
Pergolide
Cyclic AMP Receptors
Quinpirole
Spiperone
Adrenergic Antagonists
Bromocriptine
HEK293 Cells
Dopamine Receptors
GTP-Binding Proteins
Propranolol
Glioma
Inhibitory Concentration 50

ASJC Scopus subject areas

  • Pharmacology

Cite this

Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. / Watts, Val J.; Neve, Kim.

In: Molecular Pharmacology, Vol. 50, No. 4, 10.1996, p. 966-976.

Research output: Contribution to journalArticle

@article{0644973e2e8141ac802a525374f6adaf,
title = "Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors",
abstract = "Prolonged stimulation of G(i)-coupled receptors often sensitizes adenylate cyclase to subsequent activation by forskolin or G(s)coupled receptors. To identify mechanisms of heterologous sensitization, we characterized sensitization of cAMP accumulation that was induced by activation of recombinant dopamine D2 receptors expressed in C6 glioma and human embryonic kidney (HEK)293 cells. Pretreatment with dopamine or other agonists for 2 hr induced heterologous sensitization that was blocked by the D2 antagonist spiperone but not by the β-adrenergic receptor antagonist propranolol. Sensitization was evident after 15 min of treatment with dopamine and persisted for at least 2 hr after washout. The EC50 value for sensitization by dopamine in HEK-D(2L) cells was 100 nM, ~80-fold higher than the IC50 value for dopamine inhibition of cAMP accumulation. The D2 receptor agonists quinpirole, 7-hydroxy-dipropylaminotetralin, and pergolide also induced sensitization, whereas the high affinity ergot agonists bromocriptine and lisuride did not. Stimulation of either D(2L) or D(2S) receptors sensitized cAMP accumulation to similar extents, but stimulation of D3 receptors did not. In C6-D(2L) cells, sensitization of isoproterenol- stimulated activity was manifested as a >100{\%} increase in maximal response, with no change in potency. In contrast, the potency for forskolin-stimulated activity was increased 4-fold, with no apparent change in maximal response. Overnight treatment with pertussis toxin (25 ng/ml) had little effect on isoproterenol or forskolin activation of adenylate cyclase per se but prevented D2 receptor-mediated sensitization in both C6-D(2L) and HEK- D(2L) cells, indicating an involvement of one or more of the pertussis toxin- sensitive G proteins, G(i)/G(o). D2 receptor stimulation also sensitized type I and type II adenylate cyclases, each expressed in HEK293 cells together with D(2L) dopamine receptors. Rapid D2 receptor-mediated heterologous sensitization may be the result of enhanced interaction of G(s) with adenylate cyclase and may represent a novel mechanism for modulation of neural activity by D2 receptors.",
author = "Watts, {Val J.} and Kim Neve",
year = "1996",
month = "10",
language = "English (US)",
volume = "50",
pages = "966--976",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "4",

}

TY - JOUR

T1 - Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors

AU - Watts, Val J.

AU - Neve, Kim

PY - 1996/10

Y1 - 1996/10

N2 - Prolonged stimulation of G(i)-coupled receptors often sensitizes adenylate cyclase to subsequent activation by forskolin or G(s)coupled receptors. To identify mechanisms of heterologous sensitization, we characterized sensitization of cAMP accumulation that was induced by activation of recombinant dopamine D2 receptors expressed in C6 glioma and human embryonic kidney (HEK)293 cells. Pretreatment with dopamine or other agonists for 2 hr induced heterologous sensitization that was blocked by the D2 antagonist spiperone but not by the β-adrenergic receptor antagonist propranolol. Sensitization was evident after 15 min of treatment with dopamine and persisted for at least 2 hr after washout. The EC50 value for sensitization by dopamine in HEK-D(2L) cells was 100 nM, ~80-fold higher than the IC50 value for dopamine inhibition of cAMP accumulation. The D2 receptor agonists quinpirole, 7-hydroxy-dipropylaminotetralin, and pergolide also induced sensitization, whereas the high affinity ergot agonists bromocriptine and lisuride did not. Stimulation of either D(2L) or D(2S) receptors sensitized cAMP accumulation to similar extents, but stimulation of D3 receptors did not. In C6-D(2L) cells, sensitization of isoproterenol- stimulated activity was manifested as a >100% increase in maximal response, with no change in potency. In contrast, the potency for forskolin-stimulated activity was increased 4-fold, with no apparent change in maximal response. Overnight treatment with pertussis toxin (25 ng/ml) had little effect on isoproterenol or forskolin activation of adenylate cyclase per se but prevented D2 receptor-mediated sensitization in both C6-D(2L) and HEK- D(2L) cells, indicating an involvement of one or more of the pertussis toxin- sensitive G proteins, G(i)/G(o). D2 receptor stimulation also sensitized type I and type II adenylate cyclases, each expressed in HEK293 cells together with D(2L) dopamine receptors. Rapid D2 receptor-mediated heterologous sensitization may be the result of enhanced interaction of G(s) with adenylate cyclase and may represent a novel mechanism for modulation of neural activity by D2 receptors.

AB - Prolonged stimulation of G(i)-coupled receptors often sensitizes adenylate cyclase to subsequent activation by forskolin or G(s)coupled receptors. To identify mechanisms of heterologous sensitization, we characterized sensitization of cAMP accumulation that was induced by activation of recombinant dopamine D2 receptors expressed in C6 glioma and human embryonic kidney (HEK)293 cells. Pretreatment with dopamine or other agonists for 2 hr induced heterologous sensitization that was blocked by the D2 antagonist spiperone but not by the β-adrenergic receptor antagonist propranolol. Sensitization was evident after 15 min of treatment with dopamine and persisted for at least 2 hr after washout. The EC50 value for sensitization by dopamine in HEK-D(2L) cells was 100 nM, ~80-fold higher than the IC50 value for dopamine inhibition of cAMP accumulation. The D2 receptor agonists quinpirole, 7-hydroxy-dipropylaminotetralin, and pergolide also induced sensitization, whereas the high affinity ergot agonists bromocriptine and lisuride did not. Stimulation of either D(2L) or D(2S) receptors sensitized cAMP accumulation to similar extents, but stimulation of D3 receptors did not. In C6-D(2L) cells, sensitization of isoproterenol- stimulated activity was manifested as a >100% increase in maximal response, with no change in potency. In contrast, the potency for forskolin-stimulated activity was increased 4-fold, with no apparent change in maximal response. Overnight treatment with pertussis toxin (25 ng/ml) had little effect on isoproterenol or forskolin activation of adenylate cyclase per se but prevented D2 receptor-mediated sensitization in both C6-D(2L) and HEK- D(2L) cells, indicating an involvement of one or more of the pertussis toxin- sensitive G proteins, G(i)/G(o). D2 receptor stimulation also sensitized type I and type II adenylate cyclases, each expressed in HEK293 cells together with D(2L) dopamine receptors. Rapid D2 receptor-mediated heterologous sensitization may be the result of enhanced interaction of G(s) with adenylate cyclase and may represent a novel mechanism for modulation of neural activity by D2 receptors.

UR - http://www.scopus.com/inward/record.url?scp=0029860160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029860160&partnerID=8YFLogxK

M3 - Article

VL - 50

SP - 966

EP - 976

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 4

ER -